Constipation is a shared struggle for both IBS-C sufferers and individuals on GLP-1 medications
While BPC-157 is like a precise surgeon, TB-500 is more like a general contractororchestrating broad healing responses throughout the body
Dose-dependent pancreatitis risk associated with GLP-1 agonists
Early interventions, such as light fillers or collagen-stimulating treatments, can help maintain facial volume.
It hydrates and gives a bit of a tint for daily use too
Identify gaps in the literature and ongoing research directions Key gaps include a lack of large, controlled clinical trials, unclear optimal dosing and delivery for reproductive targets, limited long-term safety data for systemic use, and few mechanistic human studies linking molecular changes to fertility outcomes